Epidemiology of Acute Kidney Injury among Patients Receiving Concomitant Vancomycin and Piperacillin-Tazobactam: Opportunities for Antimicrobial Stewardship

Despite their common use as an empirical combination therapy for the better part of a decade, there has been a recent association between combination therapy with vancomycin and piperacillin-tazobactam and high rates of acute kidney injury (AKI). The reasons for this increased association are unclea...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Antimicrob Agents Chemother
Main Authors: Karino, Shigehiko, Kaye, Keith S., Navalkele, Bhagyashri, Nishan, Bakht, Salim, Madiha, Solanki, Shantanu, Pervaiz, Amina, Tashtoush, Nader, Shaikh, Hamadullah, Koppula, Sunitha, Martin, Emily T., Mynatt, Ryan P., Murray, Kyle P., Rybak, Michael J., Pogue, Jason M.
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology 2016
Teme:
Clinical Therapeutics
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4879358/
https://ncbi.nlm.nih.gov/pubmed/27067325
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.03011-15
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki